Silo Pharma prepares pre-IND package for FDA on novel ketamine formulation

Mugglehead
By Rowan DunneOct 3, 2022, 11:29 pm229 pts
Silo Pharma, Inc. (Nasdaq: SILO) has now begun working on a new ketamine drug designed to treat fibromyalgia. On Monday, the biopharmaceutical company announced that it had started collaborating with Premier Consulting as a regulatory partner to assist with preparing a pre-investigational new drug (IND)…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Why Is Texas Supporting Psychedelics Research While Criminalizing Cannabis? (Op-Ed) 63

OPP seizes thousands of cannabis plants, hundreds of pounds of flower following Health Canada referral 39

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.